LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset (ID:20249)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | Seliciclib | 0.04 | uM | LJP5 | 72 | hr | 1389 | 5996 | 5905 | 1.0155 | 1.0149 |
MCF7 | Sigma A6730 | 3.33 | uM | LJP5 | 72 | hr | 1389 | 3455 | 5905 | 0.5842 | 0.5446 |
MCF7 | WH-4-025 | 0.04 | uM | LJP5 | 72 | hr | 1389 | 5576 | 5905 | 0.9435 | 0.9443 |
MCF7 | HG-5-113-01 | 0.04 | uM | LJP5 | 72 | hr | 1389 | 5118 | 5905 | 0.8669 | 0.8678 |
MCF7 | HG-5-113-01 | 0.12 | uM | LJP5 | 72 | hr | 1389 | 4556 | 5905 | 0.7718 | 0.7667 |
MCF7 | HG-5-113-01 | 0.37 | uM | LJP5 | 72 | hr | 1389 | 3820 | 5905 | 0.6458 | 0.6201 |
MCF7 | HG-5-113-01 | 1.11 | uM | LJP5 | 72 | hr | 1389 | 2373 | 5905 | 0.4013 | 0.2906 |
MCF7 | HG-5-113-01 | 3.33 | uM | LJP5 | 72 | hr | 1389 | 1646 | 5905 | 0.2786 | 0.0840 |
MCF7 | HG-5-113-01 | 10 | uM | LJP5 | 72 | hr | 1389 | 990 | 5905 | 0.1674 | -0.1512 |
MCF7 | SB590885 | 0.04 | uM | LJP5 | 72 | hr | 1389 | 5303 | 5905 | 0.8986 | 0.9003 |
MCF7 | CP466722 | 0.04 | uM | LJP5 | 72 | hr | 1389 | 6297 | 5905 | 1.0662 | 1.0623 |
MCF7 | SB590885 | 0.37 | uM | LJP5 | 72 | hr | 1389 | 5754 | 5905 | 0.9738 | 0.9741 |
MCF7 | CP466722 | 0.12 | uM | LJP5 | 72 | hr | 1389 | 6357 | 5905 | 1.0767 | 1.0722 |
MCF7 | Seliciclib | 1.11 | uM | LJP5 | 72 | hr | 1389 | 5276 | 5905 | 0.8927 | 0.8934 |
MCF7 | CP466722 | 0.37 | uM | LJP5 | 72 | hr | 1389 | 5956 | 5905 | 1.0082 | 1.0075 |
MCF7 | Neratinib | 3.33 | uM | LJP5 | 72 | hr | 1389 | 3216 | 5905 | 0.5449 | 0.4953 |
MCF7 | CP466722 | 1.11 | uM | LJP5 | 72 | hr | 1389 | 5956 | 5905 | 1.0090 | 1.0087 |
MCF7 | Dasatinib | 0.12 | uM | LJP5 | 72 | hr | 1389 | 1822 | 5905 | 0.3085 | 0.1385 |
MCF7 | CP466722 | 3.33 | uM | LJP5 | 72 | hr | 1389 | 5916 | 5905 | 1.0023 | 1.0024 |
MCF7 | Dasatinib | 1.11 | uM | LJP5 | 72 | hr | 1389 | 937 | 5905 | 0.1588 | -0.1718 |
MCF7 | CP466722 | 10 | uM | LJP5 | 72 | hr | 1389 | 5776 | 5905 | 0.9766 | 0.9750 |
MCF7 | Neratinib | 0.04 | uM | LJP5 | 72 | hr | 1389 | 3737 | 5905 | 0.6332 | 0.6068 |
MCF7 | Neratinib | 0.12 | uM | LJP5 | 72 | hr | 1389 | 3990 | 5905 | 0.6742 | 0.6524 |
MCF7 | PD184352 | 0.37 | uM | LJP5 | 72 | hr | 1389 | 4444 | 5905 | 0.7520 | 0.7442 |
MCF7 | PD184352 | 0.12 | uM | LJP5 | 72 | hr | 1389 | 5122 | 5905 | 0.8672 | 0.8679 |